A. M. Krensky, A. Weiss, G. Crabtree, M. M. Davis, and P. Parham, Tlymphocyte-antigen interactions in transplant rejection, N Engl J Med, vol.322, p.2405272, 1990.

L. D. Cornell, R. N. Smith, and R. B. Colvin, Kidney transplantation: mechanisms of rejection and acceptance, Annu Rev Pathol, vol.3, p.18039144, 2008.

S. Hariharan, C. P. Johnson, B. A. Bresnahan, S. E. Taranto, and M. J. Mcintosh, Improved graft survival after renal transplantation in the United States, N Engl J Med, vol.342, pp.605-612, 1988.

R. I. Lechler, M. Sykes, A. W. Thomson, and L. A. Turka, Organ transplantation--how much of the promise has been realized, Nat Med, vol.11, p.15937473, 2005.

J. Dantal and J. P. Soulillou, Immunosuppressive drugs and the risk of cancer after organ transplantation, N Engl J Med, vol.352, p.15800234, 2005.

M. L. Hermiston, Z. Xu, and A. Weiss, CD45: a critical regulator of signaling thresholds in immune cells, Annu Rev Immunol, vol.21, p.12414720, 2003.

J. M. Penninger, J. Irie-sasaki, T. Sasaki, and A. J. Oliveira-dos-santos, CD45: new jobs for an old acquaintance, Nat Immunol, vol.2, p.11323691, 2001.

E. Z. Tchilian and P. C. Beverley, Altered CD45 expression and disease, Trends Immunol, vol.27, p.16423560, 2006.

M. Streuli, L. R. Hall, Y. Saga, S. F. Schlossman, and H. Saito, Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens, J Exp Med, vol.166, pp.1548-1566, 1987.

M. L. Thomas, The leukocyte common antigen family, Annu Rev Immunol, vol.7, p.2523715, 1989.

L. Ordonez, I. Bernard, L. Faqihi-olive, F. E. Tervaert, J. W. Damoiseaux et al., CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients, PLOS ONE, vol.4, p.19381293, 2009.

J. F. Subra, B. Cautain, E. Xystrakis, M. Mas, and D. Lagrange, The balance between CD45RC high and CD45RC low CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled, J Immunol, vol.166, p.11207243, 2001.

E. Xystrakis, P. Cavailles, A. S. Dejean, B. Cautain, and C. Colacios, Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat, J Immunol, vol.173, p.15322174, 2004.

G. J. Fournie, B. Cautain, E. Xystrakis, J. Damoiseaux, and M. Mas, Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases, Immunol Rev, vol.184, pp.145-160, 2001.

G. P. Spickett, M. R. Brandon, D. W. Mason, A. F. Williams, and G. R. Woollett, MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen, J Exp Med, vol.158, p.6224884, 1983.

F. Powrie, R. Correa-oliveira, S. Mauze, and R. L. Coffman, Regulatory interactions between CD45RB high and CD45RB low CD4+ T cells are important for the balance between protective and pathogenic cellmediated immunity, J Exp Med, vol.179, p.7905019, 1994.

D. Fowell, A. J. Mcknight, F. Powrie, R. Dyke, and D. Mason, Subsets of CD4+ T cells and their role in the induction and prevention of autoimmunity, Immunol Rev, vol.123, pp.37-64, 1991.

E. Xystrakis, I. Bernard, A. S. Dejean, T. Alsaati, and P. Druet, Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RC high but not the CD45RC low subset, Eur J Immunol, vol.34, p.14768045, 2004.

J. D. Davies, E. O'connor, D. Hall, T. Krahl, and J. Trotter, CD4+ CD45RB low-density cells from untreated mice prevent acute allograft rejection, J Immunol, vol.163, p.10553059, 1999.

E. Xystrakis, A. S. Dejean, I. Bernard, P. Druet, and R. Liblau, Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation, Blood, vol.104, p.15271801, 2004.

C. Guillonneau, M. Hill, F. X. Hubert, E. Chiffoleau, and C. Hervé, CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase, J Clin Invest, vol.117, p.17404623, 2007.

A. Saoudi, B. Seddon, V. Heath, D. Fowell, and D. Mason, The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset, Immunol Rev, vol.149, p.9005215, 1996.

F. Powrie and D. Mason, OX-22 high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22 low subset, J Exp Med, vol.172, p.2258700, 1990.

A. I. Lazarovits, S. Poppema, Z. Zhang, M. Khandaker, L. Feuvre et al., Prevention and reversal of renal allograft rejection by antibody against CD45RB, Nature, vol.380, p.8614467, 1996.

R. Z. Zhong and A. I. Lazarovits, Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune diseases, J Mol Med, vol.76, pp.572-580, 1998.

C. Pedros, O. Papapietro, C. Colacios, A. Casemayou, and I. Bernard, Genetic control of HgCl2-induced IgE and autoimmunity by a 117-kb interval on rat chromosome 9 through CD4 CD45RC high T cells, 2013.

, Genes Immun

N. Sarvetnick, J. Shizuru, D. Liggitt, L. Martin, and B. Mcintyre, Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma, Nature, vol.346, p.2118234, 1990.

A. S. Rosenberg, D. S. Finbloom, T. G. Maniero, P. H. Van-der-meide, and A. Singer, Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody, J Immunol, vol.144, p.2112572, 1990.

. Van-den-boogaardt, . De, P. P. Van-miert, Y. J. De-vaal, J. W. De-fijter et al., The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients, Transplantation, vol.82, p.17006334, 2006.

R. Bacchetta, M. Bigler, J. L. Touraine, R. Parkman, and P. A. Tovo, High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells, J Exp Med, vol.179, pp.493-502, 1994.

M. Hara, C. I. Kingsley, M. Niimi, S. Read, and S. E. Turvey, IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo, J Immunol, vol.166, p.11238621, 2001.

C. I. Kingsley, M. Karim, A. R. Bushell, and K. J. Wood, CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses, J Immunol, vol.168, p.11801641, 2002.

Z. Liu, H. Fan, and S. Jiang, CD4(+) T-cell subsets in transplantation, Immunol Rev, vol.252, p.23405905, 2013.

F. S. Benghiat, L. M. Charbonnier, B. Vokaer, D. Wilde, V. et al., Interleukin 17-producing T helper cells in alloimmunity, Transplant Rev (Orlando), vol.23, p.19027613, 2009.

T. Yi, D. Zhao, C. L. Lin, C. Zhang, and Y. Chen, Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease, Blood, vol.112, p.18596226, 2008.

. O'connor-w-jr, M. Kamanaka, C. J. Booth, T. Town, and S. Nakae, A protective function for interleukin 17A in T cell-mediated intestinal inflammation, Nat Immunol, vol.10, p.19448631, 2009.

S. Schnyder-candrian, D. Togbe, I. Couillin, I. Mercier, and F. Brombacher, Interleukin-17 is a negative regulator of established allergic asthma, J Exp Med, vol.203, p.17101734, 2006.

K. S. Voo, Y. H. Wang, F. R. Santori, C. Boggiano, and K. Arima, Identification of IL-17-producing FOXP3+ regulatory T cells in humans, Proc Natl Acad Sci U S A, vol.106, p.19273860, 2009.

G. Beriou, C. M. Costantino, C. W. Ashley, L. Yang, and V. K. Kuchroo, IL-17-producing human peripheral regulatory T cells retain suppressive function, Blood, vol.113, p.19171879, 2009.

S. Z. Josefowicz, L. F. Lu, and A. Y. Rudensky, Regulatory T cells: mechanisms of differentiation and function, Annu Rev Immunol, vol.30, p.22224781, 2012.

D. J. Campbell and M. A. Koch, Phenotypical and functional specialization of FOXP3+ regulatory T cells, Nat Rev Immunol, vol.11, p.21267013, 2011.

K. J. Wood, A. Bushell, and . Hester, J Regulatory immune cells in transplantation, Nat Rev Immunol, vol.12, p.22627860, 2012.

F. Sallusto, J. Geginat, and A. Lanzavecchia, Central memory and effector memory T cell subsets: function, generation, and maintenance, Annu Rev Immunol, vol.22, p.15032595, 2004.

F. Sallusto, D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia, Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature, vol.401, p.10537110, 1999.

A. B. Adams, M. A. Williams, T. R. Jones, N. Shirasugi, and M. M. Durham, Heterologous immunity provides a potent barrier to transplantation tolerance, J Clin Invest, vol.111, pp.1887-1895, 2003.

M. L. Ford, A. D. Kirk, and C. P. Larsen, Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction, Transplantation, vol.87, p.19424013, 2009.

A. Valujskikh and F. G. Lakkis, In remembrance of things past: memory T cells and transplant rejection, Immunol Rev, vol.196, pp.65-74, 2003.

B. E. Anderson, J. Mcniff, J. Yan, H. Doyle, and M. Mamula, Memory CD4+ T cells do not induce graft-versus-host disease, J Clin Invest, vol.112, p.12840064, 2003.

B. J. Chen, D. Deoliveira, X. Cui, N. T. Le, and J. Son, Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse, Blood, vol.109, p.17148592, 2007.

H. Zheng, C. Matte-martone, H. Li, B. E. Anderson, and S. Venketesan, Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease, Blood, vol.111, p.18045967, 2008.

A. E. Foster, M. Marangolo, M. M. Sartor, S. I. Alexander, and M. Hu, Human CD62L-memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion, Blood, vol.104, pp.2403-2409, 2004.

P. Sagoo, E. Perucha, B. Sawitzki, S. Tomiuk, and D. A. Stephens, Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, vol.120, p.20501943, 2010.

K. A. Newell, A. Asare, A. D. Kirk, T. D. Gisler, and K. Bourcier, Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, vol.120, p.20501946, 2010.